IP Library Granted Patent US 11,059,851
Granted Patent B2
US 11,059,851 · App. 16/311,091 · Granted Jul 13, 2021

Process for the purification of methylcobalamin

Inventors: Juan Sallares Rosell (Sant cugat del Vallès, ES); Francisco Marquillas Olondriz (Sant cugat del Vallès, ES)
Assignee: HEALTHTECH BIO ACTIVES, S.L.U.
C07H23/00C07H1/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,059,851
App. No.
16/311,091
Granted
Jul 13, 2021
Kind
B2
Abstract

The present invention relates to a process for the purification of methylcobalamin, namely from iron cyanide impurities, comprising contacting a solution comprising methylcobalamin and iron cyanide anions with a strongly basic anion exchange resin. This purification process can advantageously be used for removing iron cyanide impurities from methylcobalamin obtained by reductive methylation of cyanocobalamin and wherein iron (II) salts are used as cyanide scavengers, thus providing methylcobalamin with a reduced iron content. Methylcobalamin (R is methyl).

Claims (19)

1. Process for the purification of methylcobalamin from mixtures with iron cyanide anions characterized in that it comprises contacting a solution comprising methylcobalamin and iron cyanide anions with a strongly basic anion exchange resin.

2. Process according to claim 1 , characterized in that the strongly basic anion exchange resin has trialkylammonium functional groups and interchanges chloride anions.

3. Process according to claim 1 , characterized in that the resin is selected from a crosslinked polystyrene-divinylbenzene resin and a crosslinked acrylic-divinylbenzene resin.

4. Process according to claim 1 , characterized in that the resin is a crosslinked acrylic-divinylbenzene resin having macroreticular structure.

5. Process according to claim 1 , characterized in that the process of contacting the solution comprising methylcobalamin and iron cyanide anions with the strongly basic anion exchange resin is performed by passing the solution through an effective amount of the resin over a period of time comprised between 2 and 6 hours.

6. Process according to claim 1 , characterized in that the weight ratio resin:methylcobalamin is comprised between 0.1:1 and 2:1.

7. Process according to claim 6 , characterized in that the weight ratio resin:methylcobalamin is approximately 0.5:1.

8. Process according to claim 1 , characterized in that the solvent used in the solution is selected from water and a mixture of water with an water-miscible organic co-solvent.

9. Process according to claim 8 , characterized in that the solvent is a mixture of water and a water-miscible organic co-solvent.

10. Process according to claim 9 , characterized in that the solvent is a mixture of water and acetone.

11. Process according to claim 9 , characterized in that the volume proportion water:organic co-solvent is comprised between 1.8:1 and 1:1.5.

12. Process according to claim 1 , characterized in that methylcobalamin is crystallized from the solution collected after the treatment with the resin.

13. Process according to claim 1 , characterized in that the solution which is subjected to the purification process is prepared by treating methylcobalamin comprising iron cyanide impurities with the solvent, heating to a temperature comprised between 30° C. and 60° C., and filtering to remove insoluble impurities.

14. Process according to claim 1 , characterized in that the methylcobalamin which is purified is obtained by reductive methylation of cyanocobalamin in the presence of iron (II) salts and optionally iron (III) salts as cyanide scavengers.

15. Process according to claim 1 , characterized in that the methylcobalamin obtained has a content of iron of less than 130 ppm.

16. Process according to claim 2 , characterized in that the resin is selected from a crosslinked polystyrene-divinylbenzene resin and a crosslinked acrylic-divinylbenzene resin.

17. Process according to claim 2 , characterized in that the resin is a crosslinked acrylic-divinylbenzene resin having macroreticular structure.

18. Process according to claim 3 , characterized in that the resin is a crosslinked acrylic-divinylbenzene resin having macroreticular structure.

19. Process according to claim 2 , characterized in that the process of contacting the solution comprising methylcobalamin and iron cyanide anions with the strongly basic anion exchange resin is performed by passing the solution through an effective amount of the resin over a period of time comprised between 2 and 6 hours.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2020
From: INTERQUIM, S.A.
To: HEALTHTECH BIO ACTIVES, S.L.U.
Reel/Frame 053466/0233 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2018
From: SALLARES ROSELL, JUAN; MARQUILLAS OLONDRIZ, FRANCISCO
To: INTERQUIM, S.A.
Reel/Frame 047814/0501 →
Priority Claims (1)
EP 16178560 · Jul 8, 2016 · regional
Continuity (1)
Related Publication 20200308217A1 · Oct 1, 2020